Exciting developments in immunotherapy concerning CAR-T, CAR-T for solid tumours and immune checkpoint inhibitors

Immunotherapy has been around since the eighteenth century, when it was noticed that patients suffering with cancer would sometimes go into remission after suffering from a fever. However it wasn’t until the 1890s that someone started to carry out scientific research on this. William Coley carried out experiments where streptococcal cultures were injected into cancer patients, and regression was seen …

Juno Therapeutics CAR-T JCAR015 trial – how you can meet them this November

In early July 2016, Juno Therapeutics stock value plummeted by an unprecedented 27% after three patients died in a clinical trial testing their lead cancer therapy. After this, US regulators put this trial on pause, causing questions to be asked about the safety of the new approaches to battling cancer. The trial in question was being tested on adults with …